Literature DB >> 10711471

Role of selective intra-operative cholangiography during cholecystectomy.

G Singh1, P C Gupta, G Sridar, R N Katariya.   

Abstract

BACKGROUND: The use of routine intra-operative cholangiography (IOC) remains controversial. This prospective study was carried out to determine whether to perform selective or routine IOC in patients undergoing cholecystectomy for gallstones.
METHODS: All consecutive patients undergoing open cholecystectomy over a 16-month period were included in the present study. They were divided into two groups based on the absence (n = 79) or presence (n = 55) of indicators of choledocholithiasis. All patients were subjected to cholangiography. Each indicator, subsets of indicators and all indicators combined were evaluated for their ability to predict choledocholithiasis.
RESULTS: There would be only two missed stones (1.5%) if selective cholangiography was to be practised. Intra-operative cholangiography had a positive predictive value of 100%. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of all the indicators combined were 93.5%, 84.6%, 74.5%, 97.5% and 88.0%, respectively. The best indicators in each subset were jaundice, common bile duct diameter as assessed by ultrasonography, and a palpable stone during surgery with NPV of 82.7%, 91.1% and 96.8%, respectively.
CONCLUSION: Routine IOC during cholecystectomy is not essential for the prevention of retained stones. A combination of the various indicators of choledocholithiasis can be used to select patients for cholangiography.

Entities:  

Mesh:

Year:  2000        PMID: 10711471     DOI: 10.1046/j.1440-1622.2000.01765.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  7 in total

1.  SAGES clinical spotlight review: intraoperative cholangiography.

Authors:  William W Hope; Robert Fanelli; Danielle S Walsh; Vimal K Narula; Ray Price; Dimitrios Stefanidis; William S Richardson
Journal:  Surg Endosc       Date:  2017-03-31       Impact factor: 4.584

2.  The role of intraoperative cholangiography in patients undergoing laparoscopic cholecystectomy for acute gallstone pancreatitis: is magnetic resonance cholangiopancreatography needed?

Authors:  A Thacoor; T W Pike; S Pathak; J Dixon; C Macutkiewicz; A M Smith
Journal:  Ann R Coll Surg Engl       Date:  2019-06-03       Impact factor: 1.891

3.  Prospective evaluation of a selective approach to cholangiography for suspected common bile duct stones.

Authors:  James Horwood; Fayaz Akbar; Katherine Davis; Richard Morgan
Journal:  Ann R Coll Surg Engl       Date:  2010-03-10       Impact factor: 1.891

Review 4.  Endoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones.

Authors:  Kurinchi Selvan Gurusamy; Vanja Giljaca; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

Review 5.  Ultrasound versus liver function tests for diagnosis of common bile duct stones.

Authors:  Kurinchi Selvan Gurusamy; Vanja Giljaca; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

6.  For patients with predicted low risk for choledocholithiasis undergoing laparoscopic cholecystectomy, selective intraoperative cholangiography and postoperative endoscopic retrograde cholangiopancreatography is an effective strategy to limit unnecessary procedures.

Authors:  Michael F Byrne; Mark T McLoughlin; Robert M Mitchell; Henning Gerke; K Kim; Theodore N Pappas; M S Branch; Paul S Jowell; John Baillie
Journal:  Surg Endosc       Date:  2008-12-31       Impact factor: 4.584

7.  Role of intraoperative cholangiography for detecting residual stones after biliary pancreatitis: still useful? A retrospective study.

Authors:  Abdelrahman Abdelaal; Moamena El-Matbouly; Ibnouf Sulieman; Ahmad Elfaki; Tamer El-Bakary; Sherif Abdelaziem; Salahdin Gehani; Adriana Toro; Isidoro Di Carlo
Journal:  World J Emerg Surg       Date:  2017-04-20       Impact factor: 5.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.